|本期目录/Table of Contents|

[1]高俊巧 李峰 刘燕 吴卓耘 王淑艳 宋月晗.中药治疗创伤后应激障碍临床试验的系统评价[J].环球中医药,2016,9(08):1027-1032.[doi:10.3969/j.issn.1674-1749.2016.08.041]
 GAO Jun-qiao,LI Feng,LIU Yan,et al.Systematic review of clinical trials of traditional Chinese medicine in the treatment of posttraumatic stress disorder[J].,2016,9(08):1027-1032.[doi:10.3969/j.issn.1674-1749.2016.08.041]
点击复制

中药治疗创伤后应激障碍临床试验的系统评价()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第9卷
期数:
2016年08期
页码:
1027-1032
栏目:
综述
出版日期:
2016-08-06

文章信息/Info

Title:
Systematic review of clinical trials of traditional Chinese medicine in the treatment of posttraumatic stress disorder
作者:
高俊巧 李峰 刘燕 吴卓耘 王淑艳 宋月晗
100029 北京中医药大学基础医学院[高俊巧(硕士研究生)、李峰、刘燕、吴卓耘、王淑艳、宋月晗]
Author(s):
GAO Jun-qiao LI Feng LIU Yanet al.
Beijing University of Chinese Medicine, Beijing 100029,China
关键词:
中药 创伤后应激障碍 系统综述 随机对照试验
Keywords:
Chinese herbal medicine Posttraumatic stress disorder Systematic review Randomized controlled trials
分类号:
R749
DOI:
10.3969/j.issn.1674-1749.2016.08.041
文献标志码:
A
摘要:
目的 中药被广泛应用于创伤后应激障碍(posttraumatic stress disorder, PTSD)的治疗,但对其疗效和安全性尚缺乏系统的评价。笔者就中药治疗PTSD这一疾病的安全及其有效做一系统分析。方法 检索CNKI、CBM、PubMed等数据库中以中药为治疗措施,以不治疗、安慰剂、常规药物等为对照措施治疗PTSD的随机平行对照试验。对纳入的研究进行质量评价及资料提取,采用RevMan5.2.0软件进行Meta分析。结果的效应指标为标准化均数差(standardized mean difference, SMD),均以95%(confidence interval, CI)表示。结果 共纳入7篇随机对照试验(randomized controlled trails, RCTs)文章,1500例PTSD患者随机分配到治疗组和对照组。对纳入研究进行描述分析和Meta分析。Meta分析结果显示,3项随机对照临床试验,中药治疗PTSD与对照组相比,在改善患者PTSD-SS得分方面{SMD(random)-3.52,95%CI [-3.85,-3.19]}、HAMD得分方面{SMD(random)-3.66,95%CI [-4.00,-3.32]}有显著的优势。其中对于HAMA,SAS,SDS,SCL-90量表的研究进行了描述性分析,中药组在改善SAS、SDS、SCL-90量表得分方面有显著的优势,且有统计学意义(P<0.05)。1个研究在HAMA得分方面,两组无统计学意义,但中药组副作用明显低于对照组,且有显著差异(P<0.01)。结论 纳入分析的文章方法学质量不高,样本量偏小,不同研究结果一致性不强,因此,现有的临床证据不能够肯定或者否定中药在改善PTSD患者的临床症状及结局指标方面的作用,其临床有效性和安全性尚需高质量的研究结果支持。
Abstract:
Objective Chinese herbal medicine is widely used in posttraumatic stress disorder(PTSD)treatment, but the efficacy and safety were lacked of system for evaluation. So we conducted a systematic review to assess the efficacy and safety of Chinese herbal medicine in treating PTSD. Methods Retrieval of CNKI, CBM, PubMed and other databases to Chinese medicine as a treatment measure, with no treatment, placebo, conventional drugs as control measures for the treatment of PTSD randomized parallel controlled trials. Quality rating and data extraction were performed. RevMan5.2.0 software was used for meta-analysis. Standardized mean difference(SMD)at 95% confident interval(CI)was used to indicate results. Results A total of 7 randomized controlled trials were included, and 1500 patients with PTSD were randomly assigned to the treatment group and the control group. Descriptive and meta-analyses were performed in inclusive trials. Meta analysis of 3 randomized controlled clinical trials showed that the treatment of Chinese herbal medicine showed an obvious advantage compared with the control group on improving PTSD-SS function rating score{SMD(random)-3.66 95%CI [-4.00,-3.32]}. For HAMD scale, Meta analysis showed that Chinese herbal medicine was obvious advantage compared with the control group {SMD(random)-3.66 95%CI [-4.00,-332]}. The cognitive function was assessed in studying HAMA, SAS, SDS, SCL-90 scale. The results Showed SAS, SDS, SCL-90 score were better in the Chinese herbal medicine group than in the control group, the results had significant difference(P<0.05). One study indicated HAMA score in the Chinese herbal medicine group had no significant differences compared with control group. But the adverse reactions were less than control group, the result had significant difference(P<0.05). Conclusions The article quality of included trials is poor and the samples were small. Results of different trials were lack of consistency. Present evidence is not sufficient to prove or disapprove the role of Chinese herbal medicine in improving clinical symptoms and outcome indicators of PTSD patients. Its clinical effectiveness and safety are still needed high quality research results to support.

参考文献/References:

[1] American Psychiatric Association Diagnostic and statistical manual of mental disorders[M]. Fourth Edition(DSM-IV).Washington DC:American Psychiatric Publishing,1994:142-147.
[2] Davidson JR, Stein DJ, Shalev AY, et al. Posttraumatic stress disorder: acquisition, recognition, course, andtreatment[J]. J Neuropsychiatry Clin Neurosci, 2004, 16(2): 135-147.
[3] 魏品康,修丽娟,庞斌,等.白龙解郁颗粒对地震灾害创伤后应激障碍的影响[J].中医杂志,2010,51(6):510-512,530.
[4] 魏品康,施俊,武峰,等.白龙解郁颗粒对震后救援军人创伤后应激障碍的干预研究[J].第二军医大学学报,2010,31(8):921-922.
[5] 李忠义,何蕊芳.中西医结合治疗创伤后应激障碍[J].临床心身疾病杂志,2003,9(1):19-20.
[6] 赵欢,杨东东,史敏.中西医结合治疗创伤后应激障碍240例临床研究[J].中国中医基础医学杂志,2014,20(2):211-212,234.
[7] 陈赟,武燕,陈菊萍.中西医综合疗法治疗创伤后应激障碍27例临床研究[J].江苏中医药,2011,43(8):34-35.
[8] 高新立,马玲,马闯胜,等.综合疗法治疗创伤后应激障碍35例[J].中医研究,2013,26(7):30-31.
[9] Meng XZ, Wu F,Wei PK,et al. A Chinese Herbal Formula to Improve General Psychological Status in Posttraumatic Stress Disorder: A Randomized Placebo-Controlled Trial on Sichuan Earthquake Survivors[J]. Evidence-Based Complementary and Alternative Medicine,2012(1):691258.

相似文献/References:

[1]王利芬.中药联合甲氨蝶呤治疗输卵管妊娠142例[J].环球中医药,2013,6(04):284.
[2]王淙悦 喻明 王华伟等.中药应用于肿瘤转移的20年用药规律探索[J].环球中医药,2014,7(02):113.
[3]崔娣 胡晓冬 夏清青.中药联合化疗治疗晚期非小细胞肺癌疗效及对患者生存期的影响[J].环球中医药,2014,7(03):219.
[4]秦兰.宫颈癌术后同步放化疗辅以中药内服的临床观察及毒副反应分析[J].环球中医药,2013,6(06):424.
 QIN Lan..Clinical effect and toxicity reaction of radiotherapy and chemotherapy combined with Chinese medicine in treating cervical cancer[J].,2013,6(08):424.
[5]徐和,戴领,沈成英,等.基于MTT法的波棱瓜子抗肝纤维化用量初步研究[J].环球中医药,2013,6(08):589.
 XU He,DAI Ling,SHEN Cheng ying,et al.Research on the administration dosage for antihepatic fibrosis of Herpetospermum caudigerum based on MTT assay[J].,2013,6(08):589.
[6]刘永衡,郎娜,陈秀,等.中药复方逆转肿瘤多药耐药研究近况及相关PI3K/AKT/NF_(-κ)B分子通路分析[J].环球中医药,2013,6(09):704.
 LIU Yong heng,LANG Na,CHEN Xiu..Traditional Chinese medicine compound in reversal of multidrug resistance in tumors and the analysis on PI3K/AKT/NFκB molecular pathway[J].,2013,6(08):704.
[7]王雪冰,张伟,李淼,等.中药外治干预化疗相关消化道反应的疗效观察[J].环球中医药,2013,6(11):858.
[8]李炯辉,刘莹.中药治疗肿瘤放射治疗后损伤的临床研究进展[J].环球中医药,2012,5(11):869.
 LI Jiong hui,LIU Ying..Clinical research progress of TCM in treating injury after radiotherapy of tumor[J].,2012,5(08):869.
[9]王秀霞,梁玲,薛会灵,等.近5年中药治疗原发性痛经临床研究进展[J].环球中医药,2012,5(02):157.
 WANG Xiu-xia,LIANG Ling,XUE Hui-ling,et al.Study progression on treatment of primary dysmenorrhea by Chinese herbs in recent five years[J].,2012,5(08):157.
[10]吴海建 高瑞岭 张俊清等.中西医结合治疗女阴湿疹60例[J].环球中医药,2014,7(07):542.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金(81001501); 教育部高等学校博士学科点专项科研基金(20100013120005); 北京中医药大学校内自主项目(2016-JYB-JSMS-002)
作者简介: 高俊巧(1989- ),2014级在读硕士研究生。研究方向:中医“病证结合”研究。E-mail:18800105199@163.com
通讯作者: 宋月晗(1981- ),女,博士,副教授,硕士生导师。研究方向: 中医“病证结合”研究。E-mail: songyuehan1981@126
更新日期/Last Update: 2016-08-06